Acadia Pharmaceuticals ACAD Interest coverage
Interest coverage at other companies
Other financials
Where this comes from
Calculated from Acadia Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Acadia Pharmaceuticals's interest coverage.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Acadia Pharmaceuticals's interest coverage?
- Acadia Pharmaceuticals (ACAD) reported interest coverage of 2.5× in Q1 2026.
- How has Acadia Pharmaceuticals's interest coverage changed year-over-year?
- Acadia Pharmaceuticals's interest coverage decreased by 69.9% year-over-year, from 8.4× to 2.5×.
- What is the long-term trend for Acadia Pharmaceuticals's interest coverage?
- Over 4 years (2020 to 2025), Acadia Pharmaceuticals's interest coverage has grown at a -47.5% compound annual growth rate (CAGR), from -43.4× to 3.3×.
- What does interest coverage mean?
- Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.